2/24
06:47 am
argx
argenex (NASDAQ:ARGX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
argenex (NASDAQ:ARGX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
2/23
01:00 am
argx
argenx to Present at TD Cowen 46th Annual Healthcare Conference
Low
Report
argenx to Present at TD Cowen 46th Annual Healthcare Conference
2/19
01:00 am
argx
argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026
Low
Report
argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026
2/8
02:04 am
argx
Low
Report
2/3
09:06 pm
argx
Analysts May Have Underestimated Argenx SE's (ARGX) 5 year Revenue Growth [Yahoo! Finance]
Low
Report
Analysts May Have Underestimated Argenx SE's (ARGX) 5 year Revenue Growth [Yahoo! Finance]
1/31
09:57 am
argx
Argenx SE – ADR (ARGX) Sentiments Bolstered on Vyvgart FDA Priority Review Milestone [Yahoo! Finance]
Low
Report
Argenx SE – ADR (ARGX) Sentiments Bolstered on Vyvgart FDA Priority Review Milestone [Yahoo! Finance]
1/30
02:18 am
argx
Argenx's (ARGX) Vyvgart Sales Outperform Expectations Across MG and CIDP Treatments [Yahoo! Finance]
Low
Report
Argenx's (ARGX) Vyvgart Sales Outperform Expectations Across MG and CIDP Treatments [Yahoo! Finance]
1/24
06:28 am
argx
argenex (NASDAQ:ARGX) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
argenex (NASDAQ:ARGX) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
1/23
05:06 am
argx
argenex (NASDAQ:ARGX) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
argenex (NASDAQ:ARGX) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
1/20
11:01 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wells Fargo & Company from $1,264.00 to $1,317.00. They now have an "overweight" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wells Fargo & Company from $1,264.00 to $1,317.00. They now have an "overweight" rating on the stock.
1/14
08:37 am
argx
argenex (NASDAQ:ARGX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $1,000.00 price target on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $1,000.00 price target on the stock.
1/13
01:00 am
argx
argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG
Low
Report
argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG
1/12
01:00 am
argx
argenx Highlights 2026 Strategic Priorities
Low
Report
argenx Highlights 2026 Strategic Priorities
1/8
03:25 pm
argx
argenex (NASDAQ:ARGX) had its price target lowered by analysts at Citigroup Inc. from $1,124.00 to $1,091.00. They now have a "buy" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target lowered by analysts at Citigroup Inc. from $1,124.00 to $1,091.00. They now have a "buy" rating on the stock.
1/8
12:49 pm
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Truist Financial Corporation from $950.00 to $1,030.00. They now have a "buy" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Truist Financial Corporation from $950.00 to $1,030.00. They now have a "buy" rating on the stock.
1/6
01:00 am
argx
argenx to Present at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
argenx to Present at 44th Annual J.P. Morgan Healthcare Conference
1/5
01:00 am
argx
argenx Announces Leadership Transition Marking Next Evolution of Growth
Medium
Report
argenx Announces Leadership Transition Marking Next Evolution of Growth
12/24
06:15 am
argx
argenex (NASDAQ:ARGX) was upgraded by analysts at DZ Bank AG to a "strong-buy" rating.
Low
Report
argenex (NASDAQ:ARGX) was upgraded by analysts at DZ Bank AG to a "strong-buy" rating.
12/19
05:57 am
argx
argenex (NASDAQ:ARGX) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
Low
Report
argenex (NASDAQ:ARGX) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
12/18
08:05 am
argx
argenex (NASDAQ:ARGX) had its "neutral" rating reaffirmed by analysts at Robert W. Baird. They now have a $858.00 price target on the stock, down previously from $924.00.
Low
Report
argenex (NASDAQ:ARGX) had its "neutral" rating reaffirmed by analysts at Robert W. Baird. They now have a $858.00 price target on the stock, down previously from $924.00.
12/17
10:23 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Royal Bank Of Canada from $860.00 to $925.00. They now have an "outperform" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Royal Bank Of Canada from $860.00 to $925.00. They now have an "outperform" rating on the stock.
12/15
01:00 am
argx
argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
Medium
Report
argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
12/11
12:31 pm
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wells Fargo & Company from $1,095.00 to $1,316.00. They now have an "overweight" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wells Fargo & Company from $1,095.00 to $1,316.00. They now have an "overweight" rating on the stock.
12/11
08:44 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Stifel Nicolaus from $1,028.00 to $1,248.00. They now have a "buy" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Stifel Nicolaus from $1,028.00 to $1,248.00. They now have a "buy" rating on the stock.
12/8
11:03 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at JPMorgan Chase & Co. from $925.00 to $1,100.00. They now have an "overweight" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at JPMorgan Chase & Co. from $925.00 to $1,100.00. They now have an "overweight" rating on the stock.